- Joined
- Jun 5, 2017
- Messages
- 16,330
- Likes
- 70,185
Wuhan Coronavirus Thread
- Thread starter samsung11
- Start date
IndianYonko
Senior Member
- Joined
- Aug 21, 2020
- Messages
- 1,813
- Likes
- 7,918
Try from setu App. Worked fine for me.
- Joined
- Jun 5, 2017
- Messages
- 16,330
- Likes
- 70,185
IndianYonko
Senior Member
- Joined
- Aug 21, 2020
- Messages
- 1,813
- Likes
- 7,918
sajobajo
Regular Member
- Joined
- Sep 8, 2020
- Messages
- 376
- Likes
- 1,257
Which city are you trying it in? As I said, once private hospitals start doing it in good numbers things are bound to improve.
In Pune big hospitals like DMH and Symbiosis are releasing over 2000 slots a day for 18+ category and not counting the number of small and big hospitals doing anywhere from 50-250 a day. I suggest you give it one more week before wishing that Mudi wud rejin.
In Pune big hospitals like DMH and Symbiosis are releasing over 2000 slots a day for 18+ category and not counting the number of small and big hospitals doing anywhere from 50-250 a day. I suggest you give it one more week before wishing that Mudi wud rejin.
Detective Pennington
Regular Member
- Joined
- May 1, 2015
- Messages
- 714
- Likes
- 2,329
If the Wuhan lab leak theory is proven true, Biden is done, because that means the Obama admin fucked up in establishing safety protocols in the lab. Repubs will sweep 2022 congressional and 2024 presidential elections.
Hopefully we get someone like Trump, but with a little more intelligence and focus.
Hopefully we get someone like Trump, but with a little more intelligence and focus.
sorcerer
Senior Member
- Joined
- Apr 13, 2013
- Messages
- 26,919
- Likes
- 98,474
Centre approves financial assistance to 67 families of the journalists who lost their lives to Covid-19
In a suo-moto move, Ministry of Information & Broadcasting and Press Information Bureau under the guidance of Hon’ble Minister of Information & Broadcasting, Sh. Prakash Javadekar, had compiled and collated the details of journalists who lost their lives due to the pandemic in the years 2020 & 2021 and started a special drive to provide assistance to their families under the Journalist Welfare Scheme.
Today, the Central Government approved a proposal of Journalist Welfare Scheme Committee headed by Sh. Amit Khare, Secretary, Ministry of Information & Broadcasting, to provide financial relief of Rs.5lakh to each of the families of 26 journalists who died due to Covid-19. In the financial year 2020-21, the Central Government provided such assistance to 41 families of the journalists deceased due to Covid taking the total number to 67. Committee expressed their deep condolences to the families of the journalists affected due to Covid.
The Press Information Bureau pro-actively reached out to the families of many journalists who lost their lives to Covid-19 and also guided them about the scheme and filing of claims.
The committee also decided to hold JWS meetings on weekly basis so that applications for financial assistance under JWS can be processed expeditiously.
The Committee today also considered applications of 11 families of those journalists who had passed away due to reasons other than Covid-19.
The JWS meeting was also attended by other members including Shri Jaideep Bhatnagar, Principal Director General, PIB, Shri.Vikram Sahay, Joint Secretary (I&B). Journalist representatives of the Committee Sh. Santosh Thakur, Sh. Amit Kumar, Sh. Umeshwar Kumar, Ms Sarjana Sharma were present in the meeting.
Journalists and their families can apply for assistance under the Journalist Welfare Scheme (JWS) through the PIB website at https://accreditation.pib.gov.in/jws/default.aspx.
In a suo-moto move, Ministry of Information & Broadcasting and Press Information Bureau under the guidance of Hon’ble Minister of Information & Broadcasting, Sh. Prakash Javadekar, had compiled and collated the details of journalists who lost their lives due to the pandemic in the years 2020 & 2021 and started a special drive to provide assistance to their families under the Journalist Welfare Scheme.
Today, the Central Government approved a proposal of Journalist Welfare Scheme Committee headed by Sh. Amit Khare, Secretary, Ministry of Information & Broadcasting, to provide financial relief of Rs.5lakh to each of the families of 26 journalists who died due to Covid-19. In the financial year 2020-21, the Central Government provided such assistance to 41 families of the journalists deceased due to Covid taking the total number to 67. Committee expressed their deep condolences to the families of the journalists affected due to Covid.
The Press Information Bureau pro-actively reached out to the families of many journalists who lost their lives to Covid-19 and also guided them about the scheme and filing of claims.
The committee also decided to hold JWS meetings on weekly basis so that applications for financial assistance under JWS can be processed expeditiously.
The Committee today also considered applications of 11 families of those journalists who had passed away due to reasons other than Covid-19.
The JWS meeting was also attended by other members including Shri Jaideep Bhatnagar, Principal Director General, PIB, Shri.Vikram Sahay, Joint Secretary (I&B). Journalist representatives of the Committee Sh. Santosh Thakur, Sh. Amit Kumar, Sh. Umeshwar Kumar, Ms Sarjana Sharma were present in the meeting.
Journalists and their families can apply for assistance under the Journalist Welfare Scheme (JWS) through the PIB website at https://accreditation.pib.gov.in/jws/default.aspx.
sorcerer
Senior Member
- Joined
- Apr 13, 2013
- Messages
- 26,919
- Likes
- 98,474
Myths & Facts on India’s Vaccination Process
Posted On: 27 MAY 2021 12:01PM by PIB Delhi
Several myths on India’s Covid-19 vaccination program are doing the rounds. These myths are arisingdue to distorted statements, half truths and blatant lies.
Member (Health) in NITI Aayog and Chair of the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) Dr Vinod Paul addresses these myths and gives out facts on all these issues.
Here are the myths & facts.
Myth 1: Centre is not doing enough to buy vaccines from abroad
Fact: The Central Government has remained engaged continuously with all the major international vaccine manufacturers right from mid-2020. Multiple rounds of discussions have happened with Pfizer, J&J & Moderna. Government offered all assistance to have them supply and /or manufacture their vaccines in India. However, it is not that their vaccines are available in free supply. We need to understand that buying vaccines internationally is not similar to buying ‘off the shelf’ items. Vaccines are in limited supply globally, and companies have their own priorities, game-plans and compulsions in allocating finite stocks. They also give preference to countries of their origin just as our own vaccine makers have done unhesitatingly for us. As soon as Pfizer indicated vaccine availability, Central Government and the company are working together for the earliest possible import of the vaccine. As a result of GoI’s efforts, Sputnik vaccine trials got accelerated and with timely approval, Russia has already sent two tranches of vaccines & accomplishedtech-transfer to our companies that would start manufacturing very soon. We reiterate our request to all international vaccine makers to come and make in India – for India and for the world.
Myth 2: Centre has not approved vaccines available globally
Fact: The Central Government has proactively eased entry of vaccines approved by US FDA, EMA, UK's MHRA and Japan's PMDA, and WHO's Emergency Use Listing into India in April. These vaccines will not need to undergo prior bridging trials. The provision has now been further amended to waive off the trial requirement altogether for the well-established vaccines manufactured in other countries. No application of any foreign manufacturer for approval is pending with the drugs controller.
Myth 3: Centre is not doing enough to ramp up domestic production of vaccines
Fact: The Central Government is playing the role of an effective facilitator to enable more companies to produce vaccines from the early 2020. There is only 1 Indian company (Bharat Biotech) which has the IP. GoI has ensured that 3 other companies/plants will start production of Covaxin apart from enhancing Bharat Biotech’s own plants, which have increased from 1 to 4. Covaxin production by Bharat Biotech is being increased from under 1 Cr per month to 10 Cr month by October. Additionally, the three PSUs will together aim to produce upto 4.0 Cr doses by December. With constant encouragement of the Government, Serum Institute is ramping up Covishield production of 6.5 crore doses per month to 11.0 crore doses per month. GoI is also ensuring in partnership with Russia that Sputnik will be manufactured by 6 companies coordinated by Dr Reddy’s. The Union Government is supporting efforts of Zydus Cadila, BioE as well Gennova for their respective indigenous vaccines through liberal funding under Covid Suraksha scheme as also the technical support at national laboratories. Development of Bharat Biotech’s single dose intranasal vaccine is proceeding well with GoI funding, and it could be a game-changer for the world. The estimate of production of over 200 crore doses by our vaccine industry by the end of 2021 is the result of such efforts and unstinted support and partnership. How many countries can even dream of such an enormous capacity, and that too across conventional as well as cutting-edge DNA and mRNA platforms? GoI and vaccine manufacturers have worked as one Team India in this mission with seamless engagement on daily basis.
Myth 4: Centre should invoke compulsory licensing
Fact: Compulsory Licensing is not a very attractive option since it is not a ‘formula’ that matters, but active partnership, training of human resources, sourcing of raw materials and highest levels of bio-safety labs which is required. Tech transfer is the key and that remains in the hands of the company that has carried out R&D. Infact, we have gone one step ahead of Compulsory Licensing and are ensuring active partnership between Bharat Biotech & 3 other entities to enhance production of Covaxin. Similar mechanism is being followed for Sputnik. Think about this: Moderna had said in October 2020 that it will not sue any company which makes its vaccines, but still not one company has done it, which shows licensing is the least of the issues. If vaccine-making was so easy, why would even the developed world be so short of vaccine doses?
Myth 5: Centre has abdicated its responsibility to the states
Fact:The Central Government is doing all the heavy-lifting, from funding vaccine manufacturers to giving them quick approvals to ramping up production to bringing foreign vaccines to India. The vaccine procured by the Centre is supplied wholly to the states for free administration to people. All this is very much in the knowledge of the states. GoI has merely enabled states to try procuring vaccines on their own, on their explicit requests. The states very well knew the production capacity in the country and what the difficulties are in procuring vaccines directly from abroad. In fact, GoI ran the entire vaccine program from January to April & it was quite well-administrated compared to the situation in May. But states, who had not even achieved good coverage of healthcare workers and frontline workers in 3 months wanted to open up the process of vaccination and wanted more decentralisation. Health is a state subject & the liberalised vaccine policy was a result of the incessant requests being made by the states to give states more power. The fact that global tenders have not given any results only reaffirm what we have been telling the states from day one: that vaccines are in short supply in the world and it is not easy to procure them at short notice.
Myth 6: Centre is not giving enough vaccines to the states
Fact: Centre is allotting enough vaccines to the states in a transparent manner as per agreed guidelines. In fact, states are also being informed in advance of the vaccine availability. Vaccine availability is going to increase in near future and much more supply would be possible. In the non-GoI channel, states are getting 25% of the doses and private hospitals are getting 25% doses. However the hiccups and issues faced by the people in the administration of these 25% doses by the states leave a lot to be desired. The behaviour of some of our leaders, who in spite of full knowledge of the facts on vaccine supply, appear on TV daily and create panic among the people is very unfortunate. This is not the time to play politics. We need everyone to unite in this fight.
Myth 7: Centre is not taking any step to vaccinate children
Fact: As of now, no country in the world is giving vaccines to children.* Also, WHO has no recommendation on vaccinating children. There have been studies about safety of vaccines in children, which have been encouraging. Trials in children in India are also going to begin soon. However, vaccinating children should not be decided on the basis of panic in Whatsapp groups and because some politicians want to play politics. It has to be a decision taken by our scientists after adequate data is available based on trials.
*The release mentions that 'no country in the world is giving vaccines to children'. It should read 'no country in the world is giving vaccines to children under 12 years.' The other points made in that section are valid. The inadvertent typographical omission is regretted.
Posted On: 27 MAY 2021 12:01PM by PIB Delhi
Several myths on India’s Covid-19 vaccination program are doing the rounds. These myths are arisingdue to distorted statements, half truths and blatant lies.
Member (Health) in NITI Aayog and Chair of the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) Dr Vinod Paul addresses these myths and gives out facts on all these issues.
Here are the myths & facts.
Myth 1: Centre is not doing enough to buy vaccines from abroad
Fact: The Central Government has remained engaged continuously with all the major international vaccine manufacturers right from mid-2020. Multiple rounds of discussions have happened with Pfizer, J&J & Moderna. Government offered all assistance to have them supply and /or manufacture their vaccines in India. However, it is not that their vaccines are available in free supply. We need to understand that buying vaccines internationally is not similar to buying ‘off the shelf’ items. Vaccines are in limited supply globally, and companies have their own priorities, game-plans and compulsions in allocating finite stocks. They also give preference to countries of their origin just as our own vaccine makers have done unhesitatingly for us. As soon as Pfizer indicated vaccine availability, Central Government and the company are working together for the earliest possible import of the vaccine. As a result of GoI’s efforts, Sputnik vaccine trials got accelerated and with timely approval, Russia has already sent two tranches of vaccines & accomplishedtech-transfer to our companies that would start manufacturing very soon. We reiterate our request to all international vaccine makers to come and make in India – for India and for the world.
Myth 2: Centre has not approved vaccines available globally
Fact: The Central Government has proactively eased entry of vaccines approved by US FDA, EMA, UK's MHRA and Japan's PMDA, and WHO's Emergency Use Listing into India in April. These vaccines will not need to undergo prior bridging trials. The provision has now been further amended to waive off the trial requirement altogether for the well-established vaccines manufactured in other countries. No application of any foreign manufacturer for approval is pending with the drugs controller.
Myth 3: Centre is not doing enough to ramp up domestic production of vaccines
Fact: The Central Government is playing the role of an effective facilitator to enable more companies to produce vaccines from the early 2020. There is only 1 Indian company (Bharat Biotech) which has the IP. GoI has ensured that 3 other companies/plants will start production of Covaxin apart from enhancing Bharat Biotech’s own plants, which have increased from 1 to 4. Covaxin production by Bharat Biotech is being increased from under 1 Cr per month to 10 Cr month by October. Additionally, the three PSUs will together aim to produce upto 4.0 Cr doses by December. With constant encouragement of the Government, Serum Institute is ramping up Covishield production of 6.5 crore doses per month to 11.0 crore doses per month. GoI is also ensuring in partnership with Russia that Sputnik will be manufactured by 6 companies coordinated by Dr Reddy’s. The Union Government is supporting efforts of Zydus Cadila, BioE as well Gennova for their respective indigenous vaccines through liberal funding under Covid Suraksha scheme as also the technical support at national laboratories. Development of Bharat Biotech’s single dose intranasal vaccine is proceeding well with GoI funding, and it could be a game-changer for the world. The estimate of production of over 200 crore doses by our vaccine industry by the end of 2021 is the result of such efforts and unstinted support and partnership. How many countries can even dream of such an enormous capacity, and that too across conventional as well as cutting-edge DNA and mRNA platforms? GoI and vaccine manufacturers have worked as one Team India in this mission with seamless engagement on daily basis.
Myth 4: Centre should invoke compulsory licensing
Fact: Compulsory Licensing is not a very attractive option since it is not a ‘formula’ that matters, but active partnership, training of human resources, sourcing of raw materials and highest levels of bio-safety labs which is required. Tech transfer is the key and that remains in the hands of the company that has carried out R&D. Infact, we have gone one step ahead of Compulsory Licensing and are ensuring active partnership between Bharat Biotech & 3 other entities to enhance production of Covaxin. Similar mechanism is being followed for Sputnik. Think about this: Moderna had said in October 2020 that it will not sue any company which makes its vaccines, but still not one company has done it, which shows licensing is the least of the issues. If vaccine-making was so easy, why would even the developed world be so short of vaccine doses?
Myth 5: Centre has abdicated its responsibility to the states
Fact:The Central Government is doing all the heavy-lifting, from funding vaccine manufacturers to giving them quick approvals to ramping up production to bringing foreign vaccines to India. The vaccine procured by the Centre is supplied wholly to the states for free administration to people. All this is very much in the knowledge of the states. GoI has merely enabled states to try procuring vaccines on their own, on their explicit requests. The states very well knew the production capacity in the country and what the difficulties are in procuring vaccines directly from abroad. In fact, GoI ran the entire vaccine program from January to April & it was quite well-administrated compared to the situation in May. But states, who had not even achieved good coverage of healthcare workers and frontline workers in 3 months wanted to open up the process of vaccination and wanted more decentralisation. Health is a state subject & the liberalised vaccine policy was a result of the incessant requests being made by the states to give states more power. The fact that global tenders have not given any results only reaffirm what we have been telling the states from day one: that vaccines are in short supply in the world and it is not easy to procure them at short notice.
Myth 6: Centre is not giving enough vaccines to the states
Fact: Centre is allotting enough vaccines to the states in a transparent manner as per agreed guidelines. In fact, states are also being informed in advance of the vaccine availability. Vaccine availability is going to increase in near future and much more supply would be possible. In the non-GoI channel, states are getting 25% of the doses and private hospitals are getting 25% doses. However the hiccups and issues faced by the people in the administration of these 25% doses by the states leave a lot to be desired. The behaviour of some of our leaders, who in spite of full knowledge of the facts on vaccine supply, appear on TV daily and create panic among the people is very unfortunate. This is not the time to play politics. We need everyone to unite in this fight.
Myth 7: Centre is not taking any step to vaccinate children
Fact: As of now, no country in the world is giving vaccines to children.* Also, WHO has no recommendation on vaccinating children. There have been studies about safety of vaccines in children, which have been encouraging. Trials in children in India are also going to begin soon. However, vaccinating children should not be decided on the basis of panic in Whatsapp groups and because some politicians want to play politics. It has to be a decision taken by our scientists after adequate data is available based on trials.
*The release mentions that 'no country in the world is giving vaccines to children'. It should read 'no country in the world is giving vaccines to children under 12 years.' The other points made in that section are valid. The inadvertent typographical omission is regretted.
omaebakabaka
Senior Member
- Joined
- Aug 29, 2020
- Messages
- 4,945
- Likes
- 13,835
What about Moderna? Sounds like they are all putting contracts on each other to write hit articles and do fixed studies?
sorcerer
Senior Member
- Joined
- Apr 13, 2013
- Messages
- 26,919
- Likes
- 98,474
Serum Institute of India begins production of Covovax vaccine
The Serum Institute of India (SII) has begun at risk production of its second Covid-19 vaccine, Covovax, in India, according to people familiar with the development.
US biotechnology company Novavax’s protein-based Covid-19 vaccine, NVX-CoV2373, is being locally manufactured by SII under the brand name Covovax.
www.hindustantimes.com
The Serum Institute of India (SII) has begun at risk production of its second Covid-19 vaccine, Covovax, in India, according to people familiar with the development.
US biotechnology company Novavax’s protein-based Covid-19 vaccine, NVX-CoV2373, is being locally manufactured by SII under the brand name Covovax.
Serum Institute of India begins production of Covovax vaccine
US biotechnology company Novavax’s protein-based Covid-19 vaccine, NVX-CoV2373, is being locally manufactured by SII under the brand name Covovax.
www.hindustantimes.com
sorcerer
Senior Member
- Joined
- Apr 13, 2013
- Messages
- 26,919
- Likes
- 98,474
DRDO's 2-DG proved to be a 'boon' in the treatment of corona, oxygen level reached 75 to 95 in a single dose
.....................................
Santosh Goel, 70, from Indore, Madhya Pradesh, was admitted to CHI Hospital on April 14 after she was found corona positive. However, after taking treatment, hed Covid-19 report came out negative in the first week of May and was discharged on May 14. But on reaching home, Mrs. Goyal started having severe breathing problems, after which she was admitted back to the hospital CHL as a post-covid patient, who was placed on 30 litre oxygen support due to low oxygen levels. But even after that, her health was not improving, even after all the efforts, the family members of Mrs. Goyal were also very worried. More than 38 days had passed and Mrs Goyal's oxygen level was hovering around 75 to 80, while her family came to know about the medicine made by the DRDO from somewhere. The family members referred the matter to the DRDO as a case study in view of the serious situation and requested them to provide medicines DG 2.
Subsequently, 4 sachets of 2-DG medicine were given to the Goyal family from Delhi DRDO, when its first sachet was given to Mrs. Goyal last Sunday (May 23rd), a few hours later, there was a miraculous change in her health. Goyal, who had been lying on bed for the past one month, was stunned when doctors checked her oxygen level, her oxygen level had reached 94-95 with just one dose, which belongs to a healthy human being. The hard work of the doctors as well as the Goyal family paid off and they thanked the DRDO and the Government of India for this medicine.
Let us tell you that 70-year-old Smt. Goyal, who has earlier fought diseases like breast cancer, heart disease, has heart pumping and arthritis, sugar, BP, hyper tension. But even after being hit by an epidemic like corona, she did not give up and fought the infection with positive thinking, finally sitting on her bed and DRDO and thanking Prime Minister Narendra Modi when she felt her health improved. Today, Mrs. Goyal has become an inspiration for all the people of the country. A message to these people today is clear that no matter how terrible the epidemic may be, it can not only be fought but can also be won with courage and family support.
english.newstracklive.com
.....................................
Santosh Goel, 70, from Indore, Madhya Pradesh, was admitted to CHI Hospital on April 14 after she was found corona positive. However, after taking treatment, hed Covid-19 report came out negative in the first week of May and was discharged on May 14. But on reaching home, Mrs. Goyal started having severe breathing problems, after which she was admitted back to the hospital CHL as a post-covid patient, who was placed on 30 litre oxygen support due to low oxygen levels. But even after that, her health was not improving, even after all the efforts, the family members of Mrs. Goyal were also very worried. More than 38 days had passed and Mrs Goyal's oxygen level was hovering around 75 to 80, while her family came to know about the medicine made by the DRDO from somewhere. The family members referred the matter to the DRDO as a case study in view of the serious situation and requested them to provide medicines DG 2.
Subsequently, 4 sachets of 2-DG medicine were given to the Goyal family from Delhi DRDO, when its first sachet was given to Mrs. Goyal last Sunday (May 23rd), a few hours later, there was a miraculous change in her health. Goyal, who had been lying on bed for the past one month, was stunned when doctors checked her oxygen level, her oxygen level had reached 94-95 with just one dose, which belongs to a healthy human being. The hard work of the doctors as well as the Goyal family paid off and they thanked the DRDO and the Government of India for this medicine.
Let us tell you that 70-year-old Smt. Goyal, who has earlier fought diseases like breast cancer, heart disease, has heart pumping and arthritis, sugar, BP, hyper tension. But even after being hit by an epidemic like corona, she did not give up and fought the infection with positive thinking, finally sitting on her bed and DRDO and thanking Prime Minister Narendra Modi when she felt her health improved. Today, Mrs. Goyal has become an inspiration for all the people of the country. A message to these people today is clear that no matter how terrible the epidemic may be, it can not only be fought but can also be won with courage and family support.
DRDO's 2-DG proved to be a 'boon' in the treatment of corona, oxygen level reached 75 to 95 in a single dose
The corona epidemic has caused a hue and cry in the country and all over the world. Since the beginning of the epidemic, a variety of drugs ..|News Track
sorcerer
Senior Member
- Joined
- Apr 13, 2013
- Messages
- 26,919
- Likes
- 98,474
Tejas aircraft tech to be used for oxygen plant in Jalna | Pune News - Times of India
PUNE: The technology developed by Defence Research and Development Organisation (DRDO) for light combat aircraft Tejas will be used in producing medical oxygen for Covid care facilities in Jalna.
A senior DRDO scientist told TOI over the phone from New Delhi on Wednesday: “Our Defence Bioengineering and Electromedical Laboratory in Bengaluru has developed the technology in the form of a medical oxygen plant (MOP). It is an offshoot technology from the onboard oxygen generation system being developed for the light combat aircraft Tejas.”
timesofindia.indiatimes.com
PUNE: The technology developed by Defence Research and Development Organisation (DRDO) for light combat aircraft Tejas will be used in producing medical oxygen for Covid care facilities in Jalna.
A senior DRDO scientist told TOI over the phone from New Delhi on Wednesday: “Our Defence Bioengineering and Electromedical Laboratory in Bengaluru has developed the technology in the form of a medical oxygen plant (MOP). It is an offshoot technology from the onboard oxygen generation system being developed for the light combat aircraft Tejas.”
Tejas aircraft tech to be used for oxygen plant in Jalna | Pune News - Times of India
The technology developed by Defence Research and Development Organisation (DRDO) for light combat aircraft Tejas will be used in producing medical oxy
timesofindia.indiatimes.com
SKC
Senior Member
- Joined
- Aug 16, 2014
- Messages
- 9,473
- Likes
- 32,244
I think the Umang app works best for booking.
- Joined
- Oct 14, 2020
- Messages
- 28,259
- Likes
- 195,883
SKC
Senior Member
- Joined
- Aug 16, 2014
- Messages
- 9,473
- Likes
- 32,244
I think the increased production is now showing up.
I can already see private organizations getting hold of vaccines now and started vaccinating their employees.
Big Pvt Hospital chains have increased their slots and added more of their branches for vaccination.
Also at the same time I have started seeing camps being organized in many Sector's RWA for vaccination.
In coming week me may see daily average no of people getting vaccinated increased to much higher no.
LETHALFORCE
Mod
- Joined
- Feb 16, 2009
- Messages
- 29,966
- Likes
- 48,916
Republicans call for Fauci's termination over shifting position on Wuhan lab funding
Republican lawmakers are calling for Dr. Fauci to be fired over a perceived shift in position on Wuhan lab funding.
Republicans call for Fauci’s termination over shifting position on Wuhan lab funding
LETHALFORCE
Mod
- Joined
- Feb 16, 2009
- Messages
- 29,966
- Likes
- 48,916
China 'cover-up' hampering investigation into COVID origin: top US general
More than 15 months after the start of the coronavirus pandemic, the U.S. military’s top officer says the evidence of its origin remains "inconclusive" but says a "cover-up," by the Chinese government isn’t helping find the answer.
China 'cover-up' hampering investigation into COVID origin
LETHALFORCE
Mod
- Joined
- Feb 16, 2009
- Messages
- 29,966
- Likes
- 48,916
'I was right' - Donald Trump says claim ‘China virus’ came from Wuhan lab has been proven correct | The Irish Post
DONALD TRUMP has doubled down on his previous claim that Covid-19 originated out of a laboratory ...
www.irishpost.com
'I was right' - Donald Trump says claim ‘China virus’ came from Wuhan lab has been proven correct
Biden was installed using lies perpetuated by Fauci and cabal about Covid. Trump - This man gets to take all the credit.'I was right' - Donald Trump says claim ‘China virus’ came from Wuhan lab has been proven correct | The Irish Post
DONALD TRUMP has doubled down on his previous claim that Covid-19 originated out of a laboratory ...
'I was right' - Donald Trump says claim ‘China virus’ came from Wuhan lab has been proven correct
Mantospace
Regular Member
- Joined
- Dec 6, 2020
- Messages
- 374
- Likes
- 671
Now suddenly indian media giving + news. Danda chala hai lagta hau
| Thread starter | Similar threads | Forum | Replies | Date |
|---|---|---|---|---|
|
Modi & Xi will unofficial meet in Wuhan city, my home town! | China | 122 | |
| S | DDG Wuhan in Exercise | China | 3 | |
| S | Wuhan Police Conducts Anti-Terroism Exercise Before Route 2 Open | China | 2 | |
| Y | An other trip to Wuhan by Navneet Kumar Bakshi | China | 25 |
